CHS Inc. CHSCP
25.47 USD -0.05 (-0.20%)
At closeNov 10, 2026, 4:00 PM EST
25.47 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
25.44 Day range 25.58
25.47 52-week range 28.88
- YTD
- -8.05%
- 1 year
- -10.06%
News
defenseworld.net CHS (NASDAQ:CHSCP) Stock Crosses Below 50 Day Moving Average – Here’s Why CHS Inc (NASDAQ: CHSCP - Get Free Report)'s share price crossed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $26.90 and traded as low as $26.56.…
businesswire.com CORRECTING and REPLACING CHS Reports Second Quarter Fiscal Year 2026 Earnings ST. PAUL, Minn.--(BUSINESS WIRE)--Second sentence of the paragraph under the "Energy" subtitle should read: "Energy reported a pretax loss of $133.6 million for the second quarter of fiscal year…
businesswire.com CHS Reports Second Quarter Fiscal Year 2026 Earnings ST. PAUL, Minn.--(BUSINESS WIRE)--CHS Inc. today released results for its second quarter of fiscal year 2026.
defenseworld.net Financial Comparison: CHS (NASDAQ:CHSCP) vs. Fresh Del Monte Produce (NYSE:FDP) Fresh Del Monte Produce (NYSE: FDP - Get Free Report) and CHS (NASDAQ: CHSCP - Get Free Report) are both consumer staples companies, but which is the better stock? We will compare the two companies…
defenseworld.net CHS Inc (NASDAQ:CHSCP) Short Interest Down 26.9% in March CHS Inc (NASDAQ: CHSCP - Get Free Report) was the target of a significant decline in short interest during the month of March. As of March 13th, there was short interest totaling 24,806 shares, a…
defenseworld.net CHS Inc (NASDAQ:CHSCP) Sees Large Growth in Short Interest CHS Inc (NASDAQ: CHSCP - Get Free Report) saw a significant growth in short interest in February. As of February 27th, there was short interest totaling 33,945 shares, a growth of 51.7% from the…
defenseworld.net Short Interest in CHS Inc (NASDAQ:CHSCP) Expands By 70.1% CHS Inc (NASDAQ: CHSCP - Get Free Report) was the target of a large growth in short interest in January. As of January 30th, there was short interest totaling 15,627 shares, a growth of 70.1% from…
defenseworld.net Head to Head Review: CHS (NASDAQ:CHSCP) and Forafric Global (NASDAQ:AFRI) CHS (NASDAQ: CHSCP - Get Free Report) and Forafric Global (NASDAQ: AFRI - Get Free Report) are both consumer staples companies, but which is the better stock? We will compare the two companies based…
businesswire.com CHS Reports First Quarter Fiscal 2026 Earnings ST. PAUL, Minn.--(BUSINESS WIRE)--CHS today reports first quarter fiscal 2026 earnings. Net income of $260.5 million reflects strong energy results.
defenseworld.net Head-To-Head Review: AgriFORCE Growing Systems (NASDAQ:AGRI) & CHS (NASDAQ:CHSCP) CHS (NASDAQ: CHSCP - Get Free Report) and AgriFORCE Growing Systems (NASDAQ: AGRI - Get Free Report) are both consumer staples companies, but which is the better stock? We will compare the two…
defenseworld.net Reviewing Moolec Science (NASDAQ:MLEC) and CHS (NASDAQ:CHSCP) Insider and Institutional Ownership 0.1% of Moolec Science shares are held by institutional investors. 2.3% of CHS shares are held by insiders. Comparatively, 19.9% of Moolec Science shares are held…
defenseworld.net Contrasting CHS (NASDAQ:CHSCP) & Adecoagro (NYSE:AGRO) CHS (NASDAQ: CHSCP - Get Free Report) and Adecoagro (NYSE: AGRO - Get Free Report) are both consumer staples companies, but which is the better business? We will compare the two companies based on…
defenseworld.net CHS (NASDAQ:CHSCP) & Local Bounti (NYSE:LOCL) Head to Head Review CHS (NASDAQ: CHSCP - Get Free Report) and Local Bounti (NYSE: LOCL - Get Free Report) are both consumer staples companies, but which is the superior business? We will contrast the two businesses…
defenseworld.net Cadiz (NASDAQ:CDZI) and CHS (NASDAQ:CHSCP) Critical Survey Cadiz (NASDAQ: CDZI - Get Free Report) and CHS (NASDAQ: CHSCP - Get Free Report) are both consumer staples companies, but which is the better stock? We will contrast the two businesses based on the…
globenewswire.com Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting CHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors
investorplace.com 7 Ultra-Safe Dividend Stocks to Buy With Yields Over 5% Many investors are pivoting to dividend stocks for safety after the recent stock market plunge. Although the stock market has recovered quite a bit since then, this could be a temporary bounce before…
prnewswire.com CHS Reports Third Quarter Earnings Strong Global Demand Generated $547.5 Million in Net Income for Third Quarter of Fiscal Year 2023 ST. PAUL, Minn.
prnewswire.com CHS expands soybean oil refining capacity at Mankato processing plant ST. PAUL, Minn., Sept. 7, 2021 /PRNewswire/ -- CHS Inc. (NASDAQ: CHSCP), the nation's leading agribusiness cooperative, today announced a major soybean refinery expansion and renovation project at…
benzinga.com CHS Expands E15 Fuel Access In 19 Additional Fuel Terminals CHS Inc (NASDAQ: CHSCP) announced the offering of E15 fuel through 19 additional fuel terminals starting in early August 2021, expanding access to higher ethanol blend fuels. CHS is registered with…
prnewswire.com CHS Expands E15 Availability Through 19 Additional Fuel Terminals ST. PAUL, Minn., Aug. 2, 2021 /PRNewswire/ -- CHS Inc. (NASDAQ: CHSCP), the nation's leading agribusiness cooperative, will expand access to higher ethanol blend fuels by offering E15 through 19…
benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018 
benzinga.com Stocks Trading Ex Dividend For Fri., Dec. 14 2018 
benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 29th 
benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 3rd